Measurements of ligand bias and functional affinity

Nature Reviews Drug Discovery

Volumn 12, Issue 6, 2013, Pages 483-

  Kenakin, Terry ^a   Christopoulos, Arthur ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ARRESTIN; CLENBUTEROL; G PROTEIN COUPLED RECEPTOR; LIGAND;

BINDING AFFINITY; DRUG RECEPTOR BINDING; LETTER; LIGAND BINDING; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; DRUG DEVELOPMENT; HUMAN; NOTE; PHYSIOLOGY;

ANIMALS; DRUG DISCOVERY; HUMANS; SIGNAL TRANSDUCTION;

EID: 84880675341     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3954-c2     Document Type: Letter

References (10)

1. Kenakin, T. & Christopoulos, A. Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nature Rev. Drug Discov. 12, 205-216 (2013).
2. Rajagopal, S. Quantifying biased agonism: understanding the links between affinity and efficacy. Nature Rev. Drug Discov. 17 May 2013 (doi:10.1038/nrd3954-c1).
3. Colquhoun, D. Imprecision in presentation of binding studies. Trends Pharmacol. Sci. 6, 197 (1985).
4. Rasmussen, S. G. F. et al. Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature 477, 549-555 (2011).
5. Rasmussen, S. G. F. et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor. Nature 469, 175-180 (2011).
6. Yan, F., Mosier, P. D., Westkaemper, R. B. & Roth, B. L. Gα-subunits differentially alter the conformation and agonist affinity of κ-opioid receptors. Biochemistry 47, 1567-1578 (2008).
7. Black, J. W. & Leff, P. Operational models of pharmacological agonist. Proc. R. Soc. Lond. B. 220,141-162 (1983).
8. Black, J. W., Leff, P. & Shankley, N. P. An operational model of pharmacological agonism: The effect of E/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharmacol. 84, 561-571 (1985).
9. Casella, I., Ambrosio, C., Gro, M. C., Molinary, P. & Costa, T. Divergent agonist selectivity in activating β1-and β2-adrenoceptors for G-protein and arrestin coupling. Biochem. J. 438, 191-202 (2011).
10. Griffin, T., Figueroa, K. W., Liller, S. & Ehlert, F. J. Estimation of agonist affinity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/0, Gs and G15. J. Pharmacol. Exp. Ther. 321, 1193-1207 (2007).